Disease | breast cancer |
Symptom | C0151825|bone pain |
Sentences | 6 |
PubMedID- 24069136 | Large scale clinical trials have demonstrated that bisphosphonates reduce tumour burden and prevent further bone loss in animal models as well as reducing bone pain in patients with breast cancer metastasis by targeting the tumour cells, angiogenesis and the bone microenvironment. |
PubMedID- 23334120 | Conclusions: this study indicated that (177)lu-edtmp was an effective and safe treatment for palliation of metastatic bone pain in patients with prostate or breast cancer. |
PubMedID- 26237068 | A small number of trials have shown that radioisotopes can relieve bone pain in patients with breast cancer and lung cancer, while inconsistent results were produced in patients with hormone-refractory prostate cancer . |
PubMedID- 26024743 | Incidence of bone pain in patients with breast cancer treated with lipegfilgrastim or pegfilgrastim: an integrated analysis from phase ii and iii studies. |
PubMedID- 20151162 | bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study. |
PubMedID- 22903605 | Taken together, these results suggest cb(2) agonists as a novel treatment for breast cancer-induced bone pain, in which disease modifications include a reduction in bone loss, suppression of cancer growth, attenuation of severe bone pain, and increased survival without the major side effects of current therapeutic options. |
Page: 1